pubmed-article:16126783 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16126783 | lifeskim:mentions | umls-concept:C1858460 | lld:lifeskim |
pubmed-article:16126783 | lifeskim:mentions | umls-concept:C0007806 | lld:lifeskim |
pubmed-article:16126783 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:16126783 | lifeskim:mentions | umls-concept:C0041633 | lld:lifeskim |
pubmed-article:16126783 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
pubmed-article:16126783 | lifeskim:mentions | umls-concept:C0032914 | lld:lifeskim |
pubmed-article:16126783 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:16126783 | lifeskim:mentions | umls-concept:C0077932 | lld:lifeskim |
pubmed-article:16126783 | lifeskim:mentions | umls-concept:C0031928 | lld:lifeskim |
pubmed-article:16126783 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:16126783 | pubmed:dateCreated | 2005-9-12 | lld:pubmed |
pubmed-article:16126783 | pubmed:abstractText | Urotensin II (UII) is the most potent endogenous vasoconstrictor identified to date. Pre-eclampsia is associated with arteriolar vasospasm but the precise underlying mechanism is uncertain and we hypothesized that UII concentrations might also be elevated. In this study we measured UII concentrations in maternal plasma and cerebrospinal fluid (CSF), and umbilical vein plasma from pre-eclamptic (PET) and normotensive patients undergoing elective Caesarean section under spinal or combined spinal-epidural anaesthesia. | lld:pubmed |
pubmed-article:16126783 | pubmed:language | eng | lld:pubmed |
pubmed-article:16126783 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16126783 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16126783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16126783 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16126783 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16126783 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16126783 | pubmed:issn | 0007-0912 | lld:pubmed |
pubmed-article:16126783 | pubmed:author | pubmed-author:SharonNN | lld:pubmed |
pubmed-article:16126783 | pubmed:author | pubmed-author:AliNN | lld:pubmed |
pubmed-article:16126783 | pubmed:author | pubmed-author:ThompsonJ PJP | lld:pubmed |
pubmed-article:16126783 | pubmed:author | pubmed-author:WaughJJ | lld:pubmed |
pubmed-article:16126783 | pubmed:author | pubmed-author:CowledPP | lld:pubmed |
pubmed-article:16126783 | pubmed:author | pubmed-author:LambertD GDG | lld:pubmed |
pubmed-article:16126783 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16126783 | pubmed:volume | 95 | lld:pubmed |
pubmed-article:16126783 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16126783 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16126783 | pubmed:pagination | 495-9 | lld:pubmed |
pubmed-article:16126783 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:meshHeading | pubmed-meshheading:16126783... | lld:pubmed |
pubmed-article:16126783 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16126783 | pubmed:articleTitle | Effects of pre-eclampsia on maternal plasma, cerebrospinal fluid, and umbilical cord urotensin II concentrations: a pilot study. | lld:pubmed |
pubmed-article:16126783 | pubmed:affiliation | University Department of Cardiovascular Sciences (Pharmacology and Therapeutics Group), Division of Anaesthesia, Critical Care and Pain Management, University of Leicester, Leicester Royal Infirmary, UK. | lld:pubmed |
pubmed-article:16126783 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16126783 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16126783 | lld:pubmed |